Herbs (Global Traditional) · European
Bistort (Bistorta officinalis) (Bistorta officinalis)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Bistort (Bistorta officinalis) is a European medicinal herb containing tannins that provide anti-inflammatory and antimicrobial properties. The plant's astringent compounds work by reducing pro-inflammatory cytokines and inhibiting microbial growth.
Bistort (Bistorta officinalis) is a perennial herb native to Europe and Asia, with the root, rhizome, and leaves used medicinally. The plant is traditionally extracted through water-based preparations including infusions, decoctions, and tinctures that concentrate its polyphenolic compounds, primarily tannins and procyanidins.
Clinical evidence for bistort in humans is severely limited, with WebMD explicitly stating there is 'no good scientific evidence' supporting its traditional uses. The most rigorous available research is a 2020 in vitro study (PMID: 32531411) that analyzed bistort rhizome infusions using UHPLC-DAD-MS³ and demonstrated anti-inflammatory and antimicrobial activity in laboratory assays. No randomized controlled trials, meta-analyses, or human clinical studies were identified.
No clinically studied dosage ranges for human use were found in available sources. Traditional preparations included decoctions, teas, powders, and tinctures, but specific dose recommendations lack scientific validation. WebMD notes insufficient reliable information exists regarding safe dosing. Consult a healthcare provider before starting any new supplement.
Bistort (Bistorta officinalis) leaves and rhizomes contain distinct nutritional and phytochemical profiles. Young leaves (traditionally consumed in dishes like 'Easter ledger pudding' in northern England) provide moderate protein (~3-5g/100g fresh weight), dietary fiber (~2-4g/100g), and trace carbohydrates. Micronutrient content includes vitamin C (estimated 20-40mg/100g fresh leaf), vitamin A precursors (beta-carotene from chlorophyll-rich tissue), and minerals including calcium (~150-200mg/100g dry weight), potassium, iron (~2-3mg/100g dry weight), and magnesium. The rhizome is notably rich in tannins, particularly condensed tannins (proanthocyanidins) and hydrolyzable tannins (primarily gallotannins and ellagitannins), with total tannin content reaching 15-20% dry weight in the rhizome — among the highest of any European medicinal plant. Polyphenolic compounds include oxymethylanthraquinones, quercetin, kaempferol glycosides, and (+)-catechin. The rhizome also contains starch (~30-35% dry weight) and emodin. Oxalic acid is present in leaves (limiting bioavailability of calcium and iron), and the high tannin content in rhizome preparations reduces protein digestibility and mineral absorption. Bioavailability of polyphenols is estimated as moderate, subject to gut microbiome metabolism into bioactive metabolites.
Bistort's tannins exert anti-inflammatory effects by suppressing the production of pro-inflammatory cytokines including IL-1β, TNF-α, and IL-8 in neutrophils. The antimicrobial activity stems from tannin compounds that disrupt bacterial cell walls and inhibit pathogen adhesion to tissues.
Laboratory studies on human neutrophils demonstrated significant reduction in inflammatory markers IL-1β, TNF-α, and IL-8 following bistort extract treatment (PMID: 32531411). In vitro antimicrobial testing showed measurable activity against common skin pathogens, though specific inhibition concentrations were not fully characterized. Currently, no human clinical trials have been conducted to validate these laboratory findings. The evidence remains limited to preliminary cell culture and antimicrobial assay studies.
Bistort is generally considered safe when used topically or in small amounts orally, though comprehensive safety data is lacking. High tannin content may cause gastrointestinal irritation, nausea, or constipation with excessive internal use. The herb may theoretically interfere with iron absorption due to tannin content and could interact with anticoagulant medications. Safety during pregnancy and lactation has not been established, so use should be avoided during these periods.
